Asthma Drugs Counter-regulate interleukin-8 Release Stimulated by Sodium Sulfite in an A549 Cell Line

References

• Ninan T K, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992; 304: 873–875
   PubMed Web of Science ®Google Scholar
• Omran M, Russell G. Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren. BMJ 1996; 312: 34
   PubMed Web of Science ®Google Scholar
• Downs S H, Marks G B, Sporik R, Belosouva E G, Car N G, Peat J K. Continued increase in the prevalence of asthma and atopy. Arch Dis Child 2001; 84: 20–23
   PubMed Web of Science ®Google Scholar
• Davies R J, Rusznak C, Devalia J L. Why is allergy increasing?Environmental factors. Clin Exp Allergy 1998; 28: 8–14
   PubMed Web of Science ®Google Scholar
• Balmes J R, Fine J M, Gordon T, Sheppard D. Potential bronchoconstrictor stimuli in acid fog. Environ Health Perspect 1989; 79: 163–166
   PubMed Web of Science ®Google Scholar
• Basbaum C, Gallup M, Gum J, Kim Y, Jany B. Modification of mucin gene expression in the airways of rats exposed to sulfur dioxide. Biorheology 1990; 27: 485–489
   PubMed Web of Science ®Google Scholar
• Pelletier M, Lavastre V, Girard D. Activation of human epithelial lung a549 cells by the pollutant sodium sulfite: enhancement of neutrophil adhesion. Toxicol Sci 2002; 69: 210–216
   PubMedGoogle Scholar
• Borish L C, Steinke J W. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111: S460–475
   PubMedGoogle Scholar
• Djukanović R, Roche W R, Wilson J W, Beasley C R, Twentyman O P, Howarth R H, Holgate S T. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434–457
   PubMed Web of Science ®Google Scholar
• Anticevich S Z, Hughes J M, Black J L, Armour C L. Induction of hyperresponsiveness in human airway tissue by neutrophils–mechanism of action. Clin Exp Allergy 1996; 26: 549–556
   PubMedGoogle Scholar
• Guichard C, Pedruzzi E, Dewas C, Fay M, Pouzet C, Bens M, Vandewalle A, Ogier-Denis E, Gougerot-Pocidalo M A, Elbim C. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 2005; 280: 37021–37032
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Cheng K C, Hsu J Y, Fu L S, Chang W C, Chu J J, Chi C S. Influence of cetirizine and loratadine on granulocyte-macrophage colony-stimulating factor and interleukin-8 release in A549 human airway epithelial cells stimulated with interleukin-1beta. J Microbiol Immunol Infect 2006; 39: 206–211
   PubMedGoogle Scholar
• Li R, Meng Z, Xie J. Effects of sulfur dioxide on the expressions of EGF, EGFR, and COX-2 in airway of asthmatic rats. Arch Environ Contam Toxicol 2008; 54: 748–757
   PubMedGoogle Scholar
• Gunnison A F, Benton A W. Sulfur dioxide: Sulfite. Interaction with mammalian serum and plasma. Arch Environ Health 1971; 22: 381–388
   PubMed Web of Science ®Google Scholar
• Beck-Speier I, Lenz A G, Godleski J J. Responses of human neutrophils to sulfite. J Toxicol Environ Health 1994; 41: 285–297
   PubMed Web of Science ®Google Scholar
• Labbé P, Pelletier M, Omara F O, Girard D. Functional responses of human neutrophils to sodium sulfite (Na2SO3) in vitro. Hum Exp Toxicol 1998; 17: 600–605
   PubMedGoogle Scholar
• Tang R B, Chen S J. Evaluation of serum interleukin-8 as a marker of disease activity in acute asthma in children. J Asthma 2000; 37: 409–413
   PubMed Web of Science ®Google Scholar
• La Grutta S, Gagliardo R, Mirabella F, Pajno G B, Bonsignore G, Bousquet J, Bellia V, Vignola A M. Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med 2003; 167: 1490–1495
   PubMedGoogle Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37–40
   PubMed Web of Science ®Google Scholar
• Johnson G L, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911–1912
   PubMed Web of Science ®Google Scholar
• Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000; 12: 85–98
   PubMed Web of Science ®Google Scholar
• DiDonato J A, Hayakawa M, Rothwarf D M, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997; 388: 548–554
   PubMed Web of Science ®Google Scholar
• Ghosh S, May M J, Kopp E B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225–260
   PubMed Web of Science ®Google Scholar
• Barnes P J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998; 94: 557–572
   PubMed Web of Science ®Google Scholar
• Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989; 143: 1366–1371
   PubMed Web of Science ®Google Scholar
• Lee S W, Tsou A P, Chan H, Thomas J, Petrie K, Eugui E M, Allison A C. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A 1988; 85: 1204–1208
   PubMed Web of Science ®Google Scholar
• Scheinman R I, Cogswell P C, Lofquist A K, Baldwin A S, Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283–286
   PubMed Web of Science ®Google Scholar
• Auphan N, DiDonato J A, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286–290
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes P J, Adcock I M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000; 20: 6891–6903
   PubMed Web of Science ®Google Scholar
• Ito K, Jazrawi E, Cosio B, Barnes P J, Adcock I M. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol Chem 2001; 276: 30208–30215
   PubMed Web of Science ®Google Scholar
• Greening A P, Ind P W, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219–224
   PubMed Web of Science ®Google Scholar
• Woolcock A, Lundback B, Ringdal N, Jacques L A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481–1488
   PubMed Web of Science ®Google Scholar
• Pedersen B, Dahl R, Larsen B B, Venge P. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993; 48: 377–382
   PubMed Web of Science ®Google Scholar
• Dente F L, Bancalari L, Bacci E, Bartoli M L, Carnevali S, Cianchetti S, Di Franco A, Giannini D, Vagaggini B, Testi R, Paggiaro P L. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax 1999; 54: 622–624
   PubMedGoogle Scholar
• Li X, Ward C, Thien F, Bish R, Bamford T, Bao X, Bailey M, Wilson J W, Haydn Walters E. An anti-inflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999; 160: 1493–1499
   PubMed Web of Science ®Google Scholar
• Ward C, Li X, Wang N, Zheng L, Bish R, Orsida B, Wilson J W, Thien F, Reid D W, Walters E H. Salmeterol reduces BAL IL-8 levels in asthmatics on low dose inhaled corticosteroids. Eur Respir J 1998; 12: s380
   PubMedGoogle Scholar
• Jeffery P K, Venge P, Gizycki M J, Egerod I, Dahl R, Faurschou P. Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study. Eur Respir J 2002; 20: 1378
   PubMed Web of Science ®Google Scholar
• Reid D W, Ward C, Wang N, Zheng L, Bish R, Orsida B, Walters E H. Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo. Eur Respir J 2003; 21: 994–999
   PubMed Web of Science ®Google Scholar
• Eickelberg O, Roth M, Lörx R, Bruce V, Rüdiger J, Johnson M, Block L H. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999; 274: 1005–1010
   PubMed Web of Science ®Google Scholar
• Cadepond F, Ulmann A, Baulieu E E. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997; 48: 129–156
   PubMed Web of Science ®Google Scholar
• Baouz S, Giron-Michel J, Azzarone B, Giuliani M, Cagnoni F, Olsson S, Testi R, Gabbiani G, Canonica G W. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB. Int Immunol 2005; 17: 1473–1481
   PubMed Web of Science ®Google Scholar
• Barnes P J. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 2002; 19: 182–191
   PubMed Web of Science ®Google Scholar
• Lovén J, Svitacheva N, Jerre A, Miller-Larsson A, Korn S H. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor. Eur Respir J 2007; 30: 848–856
   PubMed Web of Science ®Google Scholar
• Drazen J M, Israel E, O'Byrne P M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197–206
   PubMed Web of Science ®Google Scholar
• Noonan M J, Chervinsky P, Brandon M, Zhang J, Kundu S, McBurney J, Reiss T F. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. Eur Respir J 1998; 11: 1232–1239
   PubMed Web of Science ®Google Scholar
• Knorr B, Matz J, Bernstein J A, Nguyen H, Seidenberg B C, Reiss T F, Becker A. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 1998; 279: 1181–1186
   PubMed Web of Science ®Google Scholar
• Stelmach I, Korzeniewska A, Stelmach W, Majak P, Grzelewski T, Jerzynska J. Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. Ann Allergy Asthma Immunol 2005; 95: 372–380
   PubMed Web of Science ®Google Scholar
• Tahan F, Jazrawi E, Moodley T, Rovati G E, Adcock I M. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity. Clin Exp Allergy 2008; 38: 805–811
   PubMed Web of Science ®Google Scholar